Info

FibroGen is a biotechnology-based drug discovery company. FibroGen is focused on the discovery, development, and commercialization of new treatments for fibrosis, anemia, conditions associated with tissue damage or injury, and cancer based on our scientific leadership in tissue fibrosis and HIF biology. FibroGen also develops and produces recombinant human collagens and gelatins using unique production technology that provides the basis for our proprietary cosmetic dermal filler and biomaterials supply business.